Blog

By John Sinden, CEO of Glialign Drug discovery and development has never been more of a focus, for the public, researchers and investors. Cell and gene therapies are often regarded as a silver bullet of the future, but what challenges stand in the way? Key successes and challenges for cell and gene therapy Cell and […]

Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two halves, starting his journey in large, international corporations, then transitioning into the SME and start-up arena. Born in the UK, educated in the UK & USA and having led a truly international career, he offers a unique view on leadership, work […]

Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S portfolio company Perfectus Biomed and US-based Extherid Biosciences. There are of course specific challenges for a UK/US merger, but the value of cross-cultural collaboration across all levels of the business should be celebrated particularly for the personal growth and development […]